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1428Objective: Neurologic events after coronary artery bypass grafting are an infrequent but devastating complica-
tion. This study analyzed the preoperative predictive abilities of the CHADS2 and CHA2DS2VASc stroke scores
in patients undergoing isolated coronary artery bypass grafting.
Methods: Included in the study were 2910 patients who underwent isolated coronary artery bypass grafting dur-
ing a 19-year period. CHADS2 and CHA2DS2VASc scores were computed for all patients, and outcomes were
evaluated in terms of perioperative stroke and compared with 2 specific models for predicting surgical coronary
artery bypass grafting stroke (Northern New England Cardiovascular Disease Study Group and Multicenter
Study of Perioperative Ischemia Research Group). Perioperative stroke discrimination was quantified by com-
puting the area under the receiver operating characteristic curve.
Results: Overall, 62 (2.1%) had perioperative strokes. Areas under the curve were 0.71 (95% confidence inter-
val, 0.64-0.78) for CHADS2, 0.72 (95% confidence interval, 0.65-0.79) for CHA2DS2VASc, 0.69 (95% confi-
dence interval, 0.61-0.76) for Northern New England Cardiovascular Disease Study Group, and 0.73 (95%
confidence interval, 0.67-0.80) for Multicenter Study of Perioperative Ischemia Research Group scores. North-
ern New England Cardiovascular Disease Study Group and CHA2DS2VASc scores were better at discriminating
patients with particularly low or high risk of stroke.
Conclusions: CHADS2 and CHA2DS2VASc scores predicted perioperative coronary artery bypass grafting
strokes with discriminatory abilities similar to those of specific predictive surgical coronary artery bypass graft-
ing stroke models. All schemes tested showed similar limitations in discriminating patients with high postoper-
ative stroke risk, with a high proportion being classified as having intermediate stroke risk. (J Thorac Cardiovasc
Surg 2012;144:1428-35)Stroke remains a devastating complication after surgical
coronary artery bypass grafting (CABG), with an incidence
of between 1% to 5.6% remaining despite the continuous
modification of operative procedures and improvement in
intraoperative and postoperative care.1-5 The ability to
predict perioperative stroke is crucial, and many relevant
prognostic tools have been developed to discriminate
patients at high risk, such as the Northern New England
Cardiovascular Disease Study Group (NNECDSG) and
the Multicenter Study of Perioperative Ischemia Research
Group (McSPI) scores.4,5 Neither of the aforementioned
methods, however, has been extensively applied in routine
clinical practice.e Cardiac Surgery Department, General University Hospital of Valencia, Va-
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The Journal of Thoracic and Cardiovascular SurThe CHADS2 (congestive heart failure, hypertension,
age 75 years, diabetes mellitus, previous stroke or
transient ischemic attack [TIA]) and CHA2DS2VASc
(congestive heart failure, hypertension, age 75 years
doubled, diabetes mellitus, previous stroke or TIA,
vascular disease, age 64-74 years, and sex category fe-
male) are simple risk scoring methods for stroke risk
stratification in nonvalvular atrial fibrillation popula-
tions. They have been widely applied in clinical practice
as guidelines for antithrombotic therapy but never used
before to predict preoperative stroke risk in patients
undergoing isolated CABG.6,7 These scores use similar
variables (i.e, advanced age, female sex, hypertension,
diabetes, heart failure, history of cerebrovascular
events, impaired left ventricular function, etc.) to those
computed by the specific algorithms (NNECDSG and
McSPI scores) designed to predict perioperative stroke
in isolated CABG. As a consequence, the aim of this
study was to assess how accurately and consistently
the CHADS2 and CHA2DS2VASc scores performed
in predicting perioperative stroke among patients
undergoing isolated CABG relative to NNECDSG and
McSPI scores.gery c December 2012
Abbreviations and Acronyms
AUC ¼ Area under the receiver operating
characteristic curve
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
McSPI ¼ Multicenter Study of Perioperative
Ischemia Research Group
NNECDSG ¼ Northern New England
Cardiovascular Disease Study Group
OR ¼ odds ratio
TIA ¼ transient ischemic attack
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MMATERIALS AND METHODS
Patient Cohort
The retrospective study was conducted on 3011 consecutive patients un-
dergoing isolated CABG at General University Hospital of Valencia be-
tween May 1993 and September 2011. Patients undergoing concomitant
cardiac procedures, such as valve replacement, carotid endarterectomy,
and so on, were excluded. Data were entered on a daily basis from the
time of patient referral until hospital discharge, including preoperative
and operating room data and intensive care unit and hospital stay durations.
Complete information referring to the variables used in the analysis was
available for 2910 patients. Of these patients, 101 were excluded on the
grounds of incomplete data, which made application of the risk score
schemes impossible in these cases.
Risk Stratification Schemes
The CHADS2 and CHA2DS2VASc scores were tested in our sample for
their abilities to predict perioperative stroke. Two specific predictive scores
of perioperative stroke risk designed for isolated CABG, the NNECDSG
score and the McSPI score, were used to validate our institutional results
and also to compare the predictive accuracies of the scores derived from
the CHADS2 and CHA2DS2VASc schemes.
4-7 With this aim, all patients
were scored according to the 4 score algorithms, in each case following
the exact procedure described in the corresponding study.4-7 The risk
factors used to calculate the stroke risk stratification algorithms are listed
in Table 1.
The CHADS2
6 risk stratification scheme is based on a cumulative scor-
ing system focused on 5 major risk factors: congestive heart failure, hyper-
tension, age at least 75 years, and diabetes mellitus, each scoring 1, and
history of previous stroke or TIA, scoring 2 to reflect its increased weight.
CHA2DS2VASc,
7 a new and expanded version of the CHADS2 score, in-
cludes additional factors and weighting: age of at least 75 years is as-
signed 2 points (A2), vascular disease (previous myocardial infarction,
peripheral arterial disease, aortic plaques) is assigned 1 point (V), age of
65 to 74 years is assigned 1 point (A), and female sex category (Sc) is as-
signed 1 point.
The NNECDSG score4 is a specific stroke risk algorithm that was based
on 33,062 consecutive patients undergoing isolated CABG in northern New
England between 1992 and 2001. The McSPI Stroke Risk Index5 is simi-
larly derived from data on 2017 patients from 24 different centers in the
United States. These stroke prediction models were able to discriminate be-
tween the different categories in this population, with an area under the re-
ceiver operating characteristic curve (AUC) reported in the original studies
of 0.70 (95% confidence interval [CI], 0.67-0.72) for the NNECDSG score
and 0.77 (95% CI, 0.73-0.81) for the McSPI stroke risk model.
The NNECDSG stroke index score4 is based on 7 major factors: age 55
to 59 years is assigned 1.5 points, age 60 to 64 years is assigned 2.5 points,
age 65 to 69 years is assigned 3.5 points, age 70 to 74 years is assigned 4The Journal of Thoracic and Carpoints, age 75 to 79 years is assigned 4.5 points, and age of at least 80 years
is assigned 5.5 points; being female is assigned 1 point; diabetes mellitus is
assigned1.5 points; vascular disease is assigned 2 points; renal failure is as-
signed 2 points; left ventricular ejection fraction less than 40% is assigned
1.5 points; urgent surgery is assigned 1.5 points; and emergency surgery is
assigned 2.5 points.
The McSPI score5 is similarly based on 7 major factors: unstable angina
falling into New York Heart Association functional class III or IV is as-
signed 15 points; diabetes mellitus is assigned 17 points; history of neuro-
logic disease (previous stroke or TIA) is assigned 18 points; previous
CABG is assigned 16 points; history of vascular disease is assigned 18
points; history of pulmonary disease is assigned16 points, and age is as-
signed a variable amount of points (points ¼ [age25] 3 100/70).Definition Preoperative Variables
The definition of diabetes mellitus was a fasting plasma glucose level of
at least 7.0 mmol/L (126 mg/dL) or treatment with oral hypoglycemic
agent, insulin, or both. Hypertension was assessed at a resting systolic
blood pressure greater than140 mm Hg, a resting diastolic blood pressure
greater than 90 mm Hg, or both on at least 2 occasions or current antihy-
pertensive pharmacologic treatment. The CHADS2 scheme considers heart
failure as a clinical state defined as recent exacerbation (New York Heart
Association class III or IVat admission), left ventricular fractional shorten-
ing not more than 25% according to echocardiography, or left ventricular
ejection fraction not more than 40% by ventriculography. CHA2DS2VASc
introduces a history of vascular disease variable that includes coronary ar-
tery disease (previous myocardial infarction, angina pectoris, percutaneous
coronary intervention, or CABG) and peripheral vascular disease (intermit-
tent claudication, previous surgery or percutaneous intervention on the ab-
dominal aorta or the lower extremity vessels, abdominal or thoracic
surgery, arterial and venous thrombosis). Although CHA2DS2VASc in-
cludes coronary artery disease as a vascular disease factor, in this study
this preoperative variable was not computed to avoid scoring 1 additional
point in all cases.
The NNECDSG4 proposed a scheme that combined a history of vascular
disease (cerebrovascular disease including previous stroke, previous TIA,
previous carotid surgery, carotid stenosis or bruit; lower extremity disease
including claudication, amputation, previous lower extremity bypass, ab-
sent pedal pulses, or lower extremity ulcers), renal failure (requiring dial-
ysis, preoperative serum creatinine 2 mg/dL, glomerular filtration rate
<30 mL/min/1.73m2), preoperative left ventricular ejection fraction less
than 40%, and priority of surgery assessed as urgent (operation required
within 24 hours to minimize the chance of further clinical deterioration)
or emergency (cases in which there should be no delay in providing oper-
ative intervention).
McSPI5 proposed a scheme that collected unstable angina (angina in the
presence of myocardial ischemia that requires hospitalization in an inten-
sive care unit and the use of intravenous medications for control), a history
of vascular disease (at least 1 of peripheral vascular disease, carotid steno-
sis>50%, cerebrovascular surgery, aortic disease), and a history of pulmo-
nary disease (requiring pharmacologic therapy for the treatment of chronic
pulmonary compromise, or forced expiratory volume in 1 second<75% of
predicted value).
Perioperative stroke was defined as any new (temporary or permanent,
focal or global) neurologic deficit, in accordance with the published guide-
lines, within 30 days from operation or later than 30 days for patients still in
the hospital.8 Temporary stroke included TIA, defined as fully reversible
neurologic deficits lasting less than 24 hours, and prolonged reversible is-
chemic neurologic deficits, defined as events lasting longer than 24 hours
but less than 3 weeks. All stroke outcomes in this study were diagnosed
by a neurologist and in most cases were localized by imaging studies, either
head computed tomography or magnetic resonance imaging. The study ex-
cluded cases with diffuse postoperative brain encephalopathy, presenting
as delirium, confusion, coma, seizures, prolonged alteration in mentaldiovascular Surgery c Volume 144, Number 6 1429
TABLE 1. Proportion of risk factors in 2910 isolated coronary artery bypass grafting procedures and variables included in the original stroke risk–
stratification algorithms
Variable (n ¼ 2910) CHADS26 CHA2DS2VASc7 NNECDSG4 McSPI5
Age (y, mean  SD) 64,73  9,741 Yes Yes Yes Yes
Female 561/2910 (19.28%) Yes Yes
Diabetes mellitus 1218/2910 (41.86%) Yes Yes Yes Yes
Hypertension 1665/2910 (57.22%) Yes Yes
Previous MI or CAD 313/2910 (10.76%) Yes Yes
Previous stroke or TIA 187/2910 (6.43%) Yes Yes Yes Yes
Carotid artery disease 121/2910 (4.16%) Yes Yes Yes
Congestive heart failure 717/2910 (24.64%) Yes Yes Yes
Peripheral vascular disease 331/2910 (11.37%) Yes Yes Yes
Renal failure 390/2910 (13.40%) Yes
EF<40% 317/2910 (10.89%) Yes
EF 40% 386/2910 (13.26%) Yes
Revascularization presentation
Emergency 102/2910 (3.51%) Yes
Urgent 466/2910 (16.01%) Yes
Elective 2342/2910 (80.48%)
Previous CABG 171/2910 (5.88%) Yes
Unstable angina 541/2910 (18.59%) Yes
COPD 376/2910 (12.92%) Yes
Off-pump CABG 1263/2910 (43.40%)
Body mass index (kg/m2, mean  SD) 28,51  7.174
Body surface area (m2, mean  SD) 1,87  0,176
Data represent numbers and percentages of patients except as marked. CABG, Coronary artery bypass grafting; CAD, coronary artery disease; COPD, chronic obstructive pul-
monary disease; EF, ejection fraction;McSPI, Multicenter Study of Perioperative Ischemia Research Group;MI, myocardial infarction; NNECDSG, Northern New England Car-
diovascular Disease Study Group; TIA, transient ischemic attack.
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Mstatus, combativeness, and agitation in the immediate postoperative period,
which had a significant relationship with circulatory bypass time and may
also reflect a longer exposure to anesthesia.9
Surgical Procedure, Anesthesia, and Perfusion
Seven cardiac surgeons took part in the study. Although therewere some
individual variations in the technique, most procedures were standardized.
The participating surgeons decided on the type of surgical procedure as
well as on the conduits used and vessels grafted. Most of the patients un-
derwent median sternotomy. The anesthetic technique was standardized
and consisted of low- to intermediate-dose narcotics, inhalation agents,
and paralytics. Assessment of the ascending aorta was performed intraoper-
atively by digital palpation only. Cardiopulmonary bypass (on-pump) was
carried out with nonpulsatile flow (in most cases), moderate systemic hy-
pothermia (28C-32C), and pump flow rates to achieve a mean arterial
pressure of 60 to 80 mm Hg. Proximal anastomoses were performed
with a partial occluding clamp in most patients. Only in few clinical situ-
ations (aortic calcifications in the preoperative imaging study and intrao-
perative palpation of aortic plaques) were other strategies used, such as
single aortic crossclamp technique, change of proximal anastomosis site,
total arterial graft revascularization, or the no-touch aorta strategy.3,10
These technical variables were not collected as part of this study.
Postoperative management of all patients followed standard practice
guidelines from surgery to discharge. This included admission to the
intensive care unit from the operating room, with subsequent transfer to
a ward.
Statistical Analysis
Continuous variables are presented as mean  SD, and categoric vari-
ables are shown as percentages. The variables were analyzed with the Stu-
dent t test or Mann-Whitney test (where appropriate) for continuous1430 The Journal of Thoracic and Cardiovascular Survariables and the c2 test and Fisher’s exact test for categoric variables.
Stepwise logistic regression was then performed, and it included predictors
associated with a value of P<.20 from the univariate analyses. Results are
reported as odds ratios (ORs) with associated 95% CIs. The discrimination
assesses the score effectiveness to predict which patients are likely to have
a stroke and which are not, as represented by the AUC value. The value of
each stroke risk stratification scheme that provided maximum discrimina-
tion between patients who had a stroke (ie, the optimum threshold) was ob-
tained as a trade-off decision between maximizing sensitivity and
specificity by means of the receiver operating characteristic curves. This
calibration evaluates the model’s ability to predict both the overall
perioperative stroke and the different risk groups by means of the
Hosmer-Lemeshow test. We declared the classification schemes statisti-
cally significantly different if CIs did not overlap.
The predictive accuracy of the stroke risk stratification schemes
was also studied by classifying their scores into 3 levels, distinguishing
low (<1%), intermediate (1%-3%), and high-risk (>3%) of perioperative
stroke, which would be particularly important in the decision making pro-
cess. Our criteria has been arbitrary, others authors’ comments have sug-
gested similar percentages of strokes. The Statistical Package for the
Social Sciences (SPSS version 19; IBM Corporation, Armonk, NY) was
used for the statistical analysis. Informed consent was obtained from all
subjects, and the Human Research Office of General University Hospital
of Valencia approved the study.RESULTS
Patients
Of a total of 2910 patients, 62 (2.1%) had perioperative
strokes. The rate of stroke was relatively stable from 1993
to 2011 (1.6% 1.5%) and increased with age (0.35%gery c December 2012
TABLE 2. Univariate and multivariate predictive power of risk factors for postoperative stroke events
Risk factor
Event rate (%) P value
Odds ratio (95% CI)Without risk factor With risk factor Univariate Multivariate
All predictive factors
Age 75 y 49/2460 (1.99%) 13/450 (2.89%) .314
Female 46/2349 (1.95%) 16/561 (2.85%) .261
Previous stroke or TIA 39/2723 (1.43%) 23/187 (12.29%) <.001 <.001 1.12 (1.08-1.16)
Hypertension 22/1245 (1.77%) 40/1665 (2.40%) .307
Diabetes mellitus 29/1692 (1.71%) 33/1218 (2.70%) .096 .327 1.01 (0.98-1.05)
Heart failure 32/2193 (1.46%) 30/717 (4.18%) <.001 <.001 2.92 (1.72-4.97)
Vascular disease* 43/2579 (1.66%) 19/331 (5.74%) <.001 .456 1.12 (0.82-1.52)
Renal failure 46/2520 (1.82%) 16/390 (4.10%) <.008 <.001 1.94 (1.41-2.67)
Urgent surgery 46/2444 (1.88%) 16/466 (3.43%) .058 .429 0.85 (0.58-1.25)
Emergency surgery 58/2808 (2.06%) 4/102 (3.92%) .372
Age by category
<55 y 60/2446 (2.45%) 2/464 (0.43%) .010
55-59 y 58/2537 (2.29%) 4/373 (1.07%) .195
60-64 y 56/2456 (2.28%) 6/454 (1.32%) .272
65-69 y 45/2325 (1.94%) 17/585 (2.90%) .208
70-74 y 42/2326 (1.76%) 20/584 (3.59%) .027
75-79 y 52/2545 (2.00%) 10/365 (3.01%) .516
80 y 59/2825 (2.09%) 3/85 (3.53%) .615
75 y 49/2460 (1.99%) 13/450 (2.88%) .314
65-74 y 25/1741 (0.91%) 38/1169 (3.25%) .002
In the top portion, multivariate analysis was performed when a variable had more statistical relevance in our sample. In the bottom age is analyzed independently by categorized
groups. In univariate and multivariate analyses, age is considered a dichotomous variable. CI, Confidence interval; TIA, transient ischemic attack. *Vascular disease includes
coronary artery disease, peripheral vascular disease, or a previous thromboembolism other than stroke or transient ischemic attack.
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Mfor<60 years vs 3.5% for>80 years). The proportions of
the risk factors in the 2910 patients are listed in Table 1.
Off-pump techniques were used in 43.4% of cases. Vari-
ables found to be statistically significant and included in
a logistic regression analysis to predict the development
of post-CABG stroke were previous stroke or TIA (OR,
1.12; 95% CI, 1.08-1.16), heart failure (OR, 2.92; 95%
CI, 1.72-4.97), and renal failure (OR, 1.94; 95% CI, 1.41-
2.67; Table 2).
Predictive Accuracy of the Stroke Risk Stratification
Schemes
All stroke risk stratification schemes showed a significant
increasing stroke rate value between risk levels (P<.001),
as seen in Table 3. All schemes had acceptable discriminat-
ing ability, with similar AUC values: 0.716 (95% CI, 0.64-
0.78) for CHADS2, 0.725 (95% CI 0.65-0.79) for
CHA2DS2VASc, 0.697 (95%CI 0.61-0.76) for NNECDSG,
and 0.736 (95% CI 0.67-0.80) for McSPI. The Hosmer-
Lemeshow goodness-of-fit test indicated good calibration
for all stroke risk models (Table 3). Mean SD stroke score
values for perioperative stroke, sensitivity and specificity
for each scheme, and the best cutoff values (optimum score
threshold)s are detailed in Table 4. The best sensitivities
were achieved by the McSPI (78.7%) and CHA2DS2VASc
(74.2%) scores, and the best specificities were achieved by
NNECDSG (62.4%) and McSPI (59.3%) scores.The Journal of Thoracic and CarLow and High Risks of Postoperative Stroke
CHADS2 scores less than 2, CHA2DS2VASc scores less
than 2, NNECDSG scores less than 3, and McSPI scores
less than 71.5 represent in our study the group of patients
with low risk of perioperative stroke (<1%). CHADS2
scores of at least 3, CHA2DS2VASc scores of at least 4,
NNECDSG scores of at least 6, andMcSPI scores of at least
101.5 represent the group of patients with high risk of peri-
operative stroke (>3%; Table 3).
The proportion of patients assigned to individual risk cat-
egories varied widely across the schemes, as seen in
Table 5. Those categorized as low risk (<1%) ranged
from 22.8% (NNECDSG) to 57.6% (CHADS2), whereas
those categorized as high risk (>3%) ranged from 10.1%
(McSPI) to 30% (NNECDSG). All schemes provided ac-
ceptable diagnostic accuracy, ranging from 0.67 to 0.70 in
AUC, although they misclassified a considerable number
of patients who had a stroke after surgery, as shown in
Table 5. The NNECDSG and CHA2DS2VASc scores in-
cluded the largest number of strokes in the high-risk group,
61.2% and 59.6%, respectively, and these were also the
schemes with the fewest cases of stroke in the low-risk
group, 8% and 11.3%, respectively. McSPI and CHADS2
included the largest percentages of patients without a stroke
in the low-risk group, 48.8% and 58.4%, respectively. With
a score of 0, no stroke (0%) was observed only in the
McSPI score, whereas the value ranged from 0.69%diovascular Surgery c Volume 144, Number 6 1431
TABLE 3. Perioperative stroke events in the patients in relation to the CHADS2, CHA2DS2VASc, Northern New England Cardiovascular Disease
Study Group, and Multicenter Study of Perioperative Ischemia Research Group scoring systems
Stroke events N Stroke rate P value AUC (95% CI)
CHADS2
6 <.001 0.716 (0.644-0.788)
0 4 577 0.69%
1 11 1102 0.99%
2 17 805 2.11%
3 16 305 5.25%
4 9 92 9.78%
5 4 27 14.81%
6 1 2 50.00%
CHA2DS2VASc
7 <.001 0.725 (0.654-0.795)
0 2 263 0.76%
1 5 620 0.81%
2 8 726 1.10%
3 10 644 1.55%
4 14 358 3.91%
5 14 202 6.93%
6 6 75 8.00%
7 2 19 10.53%
8 1 3 33.33%
9 0 0 0%
NNECDSG4 .001 0.697 (0.611-0.762)
0 1 139 0.72%
1 1 106 0.94%
1.5-2.5 3 421 0.71%
3-4 8 639 1.25%
4.5-5.5 11 731 1.50%
6-7 16 496 3.22%
7.5-8.5 14 262 5.34%
9-10 5 85 5.88%
10.5-11.5 3 26 11.54%
12 0 5 0.00%
McSPI5 <.001 0.736 (0.672-0.801)
25.49 0 31 0.00%
25.5-40.49 1 184 0.54%
40.5-55.49 4 551 0.72%
56.5-71.49 5 635 0.79%
71.5-86.49 18 758 2.37%
86.5-101.49 13 455 2.86%
101.5-117.49 12 223 5.38%
117.5-132.49 7 63 11.11%
132.5 2 10 20.00%
Data presented as AUC, including 95% confidence intervals (CIs). The Hosmer-Lemeshow goodness-of-fit test showed good calibration in all schemes: CHADS2, P ¼ .578;
c2 ¼ 1.09, df ¼ 2; CHA2DS2VASc, P ¼ .694, c2 ¼ 2.22, df ¼ 4; Northern New England Cardiovascular Disease Study Group (NNECDSG), P ¼ .256; c2 ¼ 10.13, df ¼ 8;
Multicenter Study of Perioperative Ischemia Research Group (McSPI), P ¼ .256, c2 ¼ 9.99, df ¼ 8. AUC, Area under receiver operating characteristic curve; CI, confidence
interval.
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M(CHADS2) to 0.76% (CHA2DS2VASc) for the other
schemes. Patients with a CHADS2 score of 1 or lower
and patients with CHA2DS2VASc score of 2 or lower had
similar incidences of postoperative strokes (0.9%). On
the other hand, the stroke rate among patients with
a CHADS2 score of at least 4 was 9.7% or more, whereas
with among those with a CHA2DS2VASc score of at least
6, it was 8% or more, consisting of groups with a very
high surgical stroke risk (Table 3).1432 The Journal of Thoracic and Cardiovascular SurDISCUSSION
This study assessed the predictive ability of CHADS2 and
CHA2DS2VASc stroke risk stratification schemes for pa-
tients undergoing isolated CABG. Our results suggest that
(1) CHADS2 and CHA2DS2VASc schemes have demon-
strated acceptable discriminatory ability (AUC >0.71)
without significant deviation from the perfect fit (significant
Hosmer- Lemeshow goodness-of-fit test); (2) these clinical
schemes yield similar discriminatory accuracies to those ofgery c December 2012
TABLE 4. Mean score values of the stroke stratification schemes and optimum score thresholds
With stroke Without stroke AUC Optimum score threshold Sensitivity Specificity
CHADS2
6 2.37  1.33 1.40  1.06 0.716 1.50 73.8% 58.1%
CHA2DS2VASc
7 3.68  1.74 2.40  1.52 0.725 2.50 74.2% 55.9%
NNECDSG4 6.18  2.54 4.52  2.38 0.697 5.25 70.5% 62.4%
McSPI5 89.69  22.53 72.50  22.05 0.736 76.85 78.7% 59.3%
Mean  SD stroke score values for postoperative stroke and no postoperative stroke, with sensitivity and specificity, for each scheme. The closest point to 100% sensitivity and
specificity was selected as the optimum score threshold. P<.001 for all schemes. AUC, Area under the receiver-operating-characteristic curve; CI, confidence interval;McSPI,
Multicenter Study of Perioperative Ischemia Research Group; NNECDSG, Northern New England Cardiovascular Disease Study Group.
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MNNECDSG and McSPI risk scores (specific for isolated
CABG surgery); (3) the NNECDSG and CHA2DS2VASc
stroke risk stratification schemes are better at discriminat-
ing patients at particularly low (<1%) and high (>3%)
risks; and (4) all the schemes considered as at intermediate
risk the large percentage of patients who had between 27%
and 50% of all perioperative strokes.
In recent decades, there have been significant changes in
the population undergoing CABG surgery.1,11
Improvements in surgical techniques have made it
possible to operate successfully on older patients with
comorbid diseases, especially cerebrovascular disease,
which may predispose them toward severe postoperative
neurologic complications. Prevention is particularly
important, because stroke patients have prolonged stays in
intensive care and a markedly higher mortality.1,2 Several
risk stratification schemes have been developed to predict
perioperative stroke after isolated CABG; however none
has been extensively applied in routine clinical practice. It
is clear that an ideal stroke risk assessment tool that is
generally applicable, simple, and widely accepted does
not exist, and that each available tool has its limitations.
Since their publication, the CHADS2 and CHA2DS2VAScTABLE 5. Stroke events in relation to stroke risk stratification models and
Low Intermediate or mode
CHADS2
6
In risk category (%) 57.6% 27.6%
Stroke events (no.) 15 (24.2%) 17 (27.4%)
Mean rate of stroke (%) 0.89% 2.11%
CHA2DS2VASc
7
In risk category (%) 30.3% 47.0%
Stroke events (no.) 7 (11.3%) 18 (29%)
Mean rate of stroke (%) 0.79% 1.31%
NNECDSG4
In risk category (%) 22.8% 47.0%
Stroke events (no.) 5 (8%) 19 (30.6%)
Mean rate of stroke (%) 0.75% 1.38%
McSPI5
In risk category (%) 48.1% 41.6%
Stroke events (no.) 10 (16.1%) 31 (50.0%)
Mean rate of stroke (%) 0.71% 2.55%
Scores were categorized into 3 perioperative stroke risk levels: low (<1%), moderate or inte
the receiver-operating-characteristic curve; CI, confidence interval; McSPI, Multicenter S
Cardiovascular Disease Study Group; SE, standard error.
The Journal of Thoracic and Carstratification schemes have proved their worth as simple
and practical schemes for the prediction of major stroke
in populations with nonvalvular atrial fibrillation. These
days, they are widely used in clinical practice and in some
guidelines for selecting certain treatments for stroke
prevention.6,7,12 Interestingly, these schemes use the same
atherothrombotic risk factors associated with increased
risk of perioperative stroke after isolated CABG surgery.
This study therefore tested CHADS2 and CHA2DS2VASc
as stratification schemes in our population of patients
undergoing isolated CABG and observed good
discriminatory accuracy in predicting perioperative stroke,
similar to that achieved by the NNECDSG and McSPI
stroke risk scores (AUC, 0.74-0.69). These results suggest
that the CHADS2 or CHA2DS2VASc could be used as
a complementary method of stratifying the preoperative
stroke risk in isolated CABG surgery.
One of the major advantages of these schemes is their
ability to classify patients into risk categories or levels. A
predictive tool should be able to make accurate predictions
in diverse settings across the range of both low- and high-
risk patients. This study showed that McSPI and CHADS2
schemes present the best discrimination (AUC, 0.70) inpredictive ability of each stroke risk scheme
rate High AUC 95% CI SE
0.704 0.633-0.775 0.036
14.6%
30 (48.3%)
7.04%
0.696 0.626-0.766 0.036
22.5%
37 (59.6%)
5.63%
0.671 0.604-0.738 0.034
30.0%
38 (61.2%)
4.34%
0.704 0.637-0.770 0.033
10.1%
21 (33.8%)
7.09%
rmediate (1%-3%), and high risk (>3%). P<.0001 for all schemes. AUC, Area under
tudy of Perioperative Ischemia Research Group; NNECDSG, Northern New England
diovascular Surgery c Volume 144, Number 6 1433
Perioperative Management Hornero et al
P
Mdiscriminating the 3 risk groups in the entire population.
They also included larger percentages of stroke-free pa-
tients in their low-risk groups, 48.8% and 58.8%, respec-
tively. Interestingly, only patients who scored 0 in the
McSPI scheme had no stroke; in the other schemes, even pa-
tients with no comorbid (score 0) had a minimal stroke rate
(<0.8%). In this regard it should be considered that there is
probably always a minimum number of strokes related to
other factors, such as preoperative atrial fibrillation or sur-
gical technique (aortic crossclamping, cardiopulmonary by-
pass) that are not considered in the schemes and are
therefore difficult to predict.
CHA2DS2VASc and NNECDSG included the highest
percentages of strokes in their high-risk group, 59.6%
and 61.2%, respectively. When the CHADS2 score was 3
or greater and the CHA2DS2VASc was 4 or greater, the
mean stroke rates were at least 7% and 5.6%, respectively.
This finding has major research implications, because it en-
ables the discrimination of patients at very high risk who
need neuroprotection during surgery (ioff-pump surgery,
aorta no-touch strategy, intraoperative epiaortic ultrasound
examination of the ascending aorta) or who could be re-
garded as candidates for percutaneous coronary revascular-
ization and possibly routine postoperative prophylactic
pharmacologic treatment.
Simplicity of these schemes may lead to inadequate dis-
crimination results, especially in patients in the intermedi-
ate (moderate) risk category. In our opinion, all the
schemes had 2 important limitations in the analyzed cohort
of patients undergoing isolated CABG. First, they consid-
ered a large percentage of patients as being in the interme-
diate risk range, from 27% (CHADS2) to 47%
(CHA2DS2VASc and NNECDSG). Second, all the schemes
included a high number of the strokes that occurred in the
intermediate-risk group, ranging from 27% to 50% of all
perioperative strokes in CHADS2 and McSPI, respectively.
This inability to differentiate patients with very different
risk levels of development of stroke is an important limiting
factor for all 4 predictive strategies assessed in this study.
This lack of ability to discriminate could be due to the ho-
mogeneity of the populations in which the models were de-
fined. Most of them were based on low-risk CABG stroke
populations and therefore by definition are not calibrated
to predict outcomes in high-risk patients.4,5,13
The most commonly accepted explanation for an age-
associated postoperative stroke appears to be the increased
presence of atherosclerosis, with occult cerebrovascular
disease as well as a higher risk of embolization.14 Our pa-
tient cohort older than 70 years had a stroke rate of 3.2%,
and McSPI was the best stroke risk stratification scheme
at discriminating patients with low stroke risk, probably be-
cause it considered age as a continuous variable. Even
though the degree and extent of occult cerebral arterial dis-
ease and their potential contribution to having a stroke are1434 The Journal of Thoracic and Cardiovascular Surnot normally known, we believe that age should be consid-
ered preoperatively in the choice of revascularization
technique.
Finally, there are some limitations to this study that need
to be considered. First, it was a retrospective, observational
study, and the conclusions derived are necessarily limited in
application. Although we have validated the CHADS2 and
CHA2DS2VASc prediction schemes for the first time in
the scientific literature, these findings still require confirma-
tion from other sources. Second, the number of subjects was
not large enough to give a robust validation. The results
themselves were statistically robust, however, with a stable
SE, and we believe they were correctly interpreted. Third,
the diagnoses of stroke and diffuse brain encephalopathy
were mutually exclusive, and this may potentially have
underestimated the real prevalence of small perioperative
strokes, even though some studies have reported diffuse
brain encephalopathy to be related mainly to intraoperative
factors, such as cardiopulmonary bypass time.9 Fourth, in
our study the categorization of risk groups was completely
arbitrary, with the only purpose of grouping patients into
simple risk groups, but it is based on other authors’ com-
ments that suggest similar percentages of strokes. Stratifica-
tion schemes for primary prevention of stroke, such as the
Atrial Fibrillation Investigators, Stroke Prevention in Atrial
Fibrillation, American College of Chest Physicians,
CHADS2, and Framingham schemes having thromboembo-
lism rates in low-, moderate-, and high-risk patients during
1 year of 1.4% or less, between 1% and 3.2%, and at least
3%, respectively.15 Finally, it is also unclear how useful
these tools could actually be in aiding resource management
as compared to the clinician’s own estimate of risk for an
individual patient.
In conclusion, this study shows that CHADS2 and
CHA2DS2VASc scores demonstrated good accuracy in pre-
dicting perioperative post-CABG stroke. with discrimina-
tory performances similar to those of the NNECDSG and
McSPI stroke risk stratification schemes in a cohort of pa-
tients who had undergone isolated CABG surgery. Further-
more, we also believe that all the schemes tested in this
study have serious limitations in discriminating high-risk
patients, because a large proportion of these were classified
as at intermediate risk.References
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